Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Allergan
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:approvalYear |
April 2015
|
| gptkbp:FDAApproved |
gptkb:Kybella
|
| gptkbp:focusesOn |
aesthetic medicine
|
| gptkbp:foundedIn |
2005
|
| gptkbp:founder |
gptkb:Keith_Leonard
|
| gptkbp:headquartersLocation |
gptkb:Calabasas,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kythera Biopharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:KybellaIndication |
treatment of submental fat (double chin)
|
| gptkbp:notableProduct |
gptkb:Kybella
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:KYTH
|
| gptkbp:bfsParent |
gptkb:Nathaniel_David
|
| gptkbp:bfsLayer |
6
|